Inventor · disambiguated record
Sander Sebastiaan Van Berkel
Also filed as: VAN BERKEL SANDER S · VAN BERKEL SANDER SEBASTIAAN
18 granted patents·19 pending applications·33 citations·filing 2012–2025
90Inventor score
Top patents by PatentIndex Score
37 records- 0192US9636421B2Sulfamide linker, conjugates thereof, and methods of preparationSYNAFFIX BV·Filed 2016·Granted May 2, 2017·14 cites·15 claims
- 0291US11338043B2Antibody-conjugates with improved therapeutic index for targeting HER2 tumours and method for improving therapeutic index of antibody-conjugatesSYNAFFIX BV·Filed 2017·Granted May 24, 2022·8 cites·10 claims
- 0390US9988661B2Process for the modification of a glycoprotein using a glycosyltransferase that is or is derived from A β(1,4)-N-acetylgalactosaminyltransferaseSYNAFFIX BV·Filed 2016·Granted Jun 5, 2018·5 cites·11 claims
- 0488US10792369B2Sulfamide linker, conjugates thereof, and methods of preparationSYNAFFIX BV·Filed 2017·Granted Oct 6, 2020·3 cites·25 claims
- 0585US11850286B2Sulfamide linker, conjugates thereof, and methods of preparationSYNAFFIX BV·Filed 2020·Granted Dec 26, 2023·1 cites·28 claims
- 0682US11299759B2Process for the modification of a glycoprotein using a glycosyltransferase that is or is derived from a β(1,4)-n-acetylgalactosaminyltransferaseSYNAFFIX BV·Filed 2018·Granted Apr 12, 2022·1 cites·9 claims
- 0778US11951175B2Bioconjugates containing sulfamide linkers for use in treatmentSYNAFFIX BV·Filed 2017·Granted Apr 9, 2024·1 cites·21 claims
- 0874US12049656B2Process for the modification of a glycoprotein using a glycosyltransferase that is or is derived from a β(1,4)-n-acetylgalactosaminyltransferaseSYNAFFIX BV·Filed 2022·Granted Jul 30, 2024·0 cites·14 claims
- 0974US2024398971A1Bioconjugates containing sulfamide linkers for use in treatmentSYNAFFIX BV·Filed 2024·Application pending·0 cites
- 1072US2025304611A1Synthesis of 6-azido-6-deoxy-2-n-acetyl-hexosamine-nucleoside diphosphateSYNAFFIX BV·Filed 2025·Application pending·0 cites
- 1170US2023127659A1Antibody-conjugates with improved therapeutic index for targeting her2 tumours and method for improving therapeutic index of antibody-conjugatesSYNAFFIX BV·Filed 2022·Application pending·0 cites
- 1268US12281135B2Synthesis of 6-azido-6-deoxy-2-n-acetyl-hexosamine-nucleoside diphosphateSYNAFFIX BV·Filed 2022·Granted Apr 22, 2025·0 cites·20 claims
- 1368US11713453B2Enzymes for trimming of glycoproteinsSYNAFFIX BV·Filed 2020·Granted Aug 1, 2023·0 cites·18 claims
- 1465US12440573B2Antibody-conjugates for targeting of tumours expressing PTK7SYNAFFIX BV·Filed 2024·Granted Oct 14, 2025·0 cites·9 claims
- 1565US2025090679A1Antibody-conjugates for targeting of tumours expressing trop-2SYNAFFIX BV·Filed 2024·Application pending·0 cites
- 1663US2023338562A1Methods for the preparation of linker payload constructsSYNAFFIX BV·Filed 2022·Application pending·0 cites
- 1763US2023226208A1Methods for the preparation of bioconjugatesSYNAFFIX BV·Filed 2023·Application pending·0 cites
- 1862US11957763B2Sulfamide linkers for use in bioconjugatesSYNAFFIX BV·Filed 2020·Granted Apr 16, 2024·0 cites·20 claims
- 1961US2025082770A1Antibody-conjugates for targeting of tumours expressing carcinoembyronic antigenSYNAFFIX BV·Filed 2024·Application pending·0 cites
- 2061US2023190951A1Conjugates of antibodies an immune cell engagersSYNAFFIX BV·Filed 2022·Application pending·0 cites
- 2161US2023330245A1Antibody-exatecan conjugatesSYNAFFIX BV·Filed 2023·Application pending·0 cites
- 2260US11590239B2Antibody-conjugates with improved therapeutic index for targeting CD30 tumours and method for improving therapeutic index of antibody-conjugatesSYNAFFIX BV·Filed 2017·Granted Feb 28, 2023·0 cites·9 claims
- 2360US2023355791A1Glycan-conjugated antibodies binding to fc-gamma receptorSYNAFFIX BV·Filed 2023·Application pending·0 cites
- 2459US2023364262A1Via cycloaddition bilaterally functionalized antibodiesSYNAFFIX BV·Filed 2022·Application pending·0 cites
- 2559US2023114866A1Via cycloaddition bilaterally functionalized antibodiesSYNAFFIX BV·Filed 2022·Application pending·0 cites
- 2659US2025262314A1Multifunctional antibodiesSYNAFFIX BV·Filed 2022·Application pending·0 cites
- 2759US2025205353A1Antibody-conjugates for targeting of tumours expressing nectin-4SYNAFFIX BV·Filed 2023·Application pending·0 cites
- 2858US10874746B2Sulfamide linkers for use in bioconjugatesSYNAFFIX BV·Filed 2017·Granted Dec 29, 2020·0 cites·14 claims
- 2958US2022096652A1Acetal-based cleavable linkersSYNAFFIX BV·Filed 2021·Application pending·0 cites
- 3057US10858641B2Enzymes for trimming of glycoproteinsSYNAFFIX BV·Filed 2017·Granted Dec 8, 2020·0 cites·15 claims
- 3157US2025367315A1Antibody-drug conjugates with masked pbd dimersSYNAFFIX BV·Filed 2025·Application pending·0 cites
- 3254US12397063B2Antibody-conjugates for targeting of tumours expressing Trop-2SYNAFFIX BV·Filed 2021·Granted Aug 26, 2025·0 cites·21 claims
- 3346US2016107999A1Substituted azadibenzocyclooctyne compounds and their use in metal-free click reactionsSYNAFFIX BV·Filed 2014·Application pending·0 cites
- 3445US2025312474A1Anthracyclins and conjugates thereofSYNAFFIX BV·Filed 2025·Application pending·0 cites
- 3542US2013066063A1Bicyclo[6.1.0]non-4-yne regents for chemical modification of oligonucleotidesHODGES JOHN COOKE·Filed 2012·Application pending·0 cites
- 3632US10351525B2Beta lactamase inhibitorsUNIV OXFORD INNOVATION LTD·Filed 2015·Granted Jul 16, 2019·0 cites·21 claims
- 3730US11046988B2Process for the modification of a glycoprotein using a β-(1,4)-N-acetylgalactosaminyl transferase or a mutant thereofSYNAFFIX BV·Filed 2015·Granted Jun 29, 2021·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Sander Sebastiaan Van Berkel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →